Develop a quantitative single-molecule imaging platform for drug discovery with Steven F. Lee. The initial focus is alpha-synuclein aggregation in Parkinson’s disease. Responsibilities include assay development, higher-throughput compound screening, image-analysis pipelines and coordination with academic and commercial partners. The role also contributes to intellectual-property strategy, customer discovery and translation into an externally usable technology. Funding initially covers 12 months.
Closes